echoloc

Kuros Biosciences Tech Stack

Bone graft biologic company with clinical evidence and global manufacturing operations

Medical Equipment Manufacturing Alpharetta, Georgia 51–200 employees Public Company

Kuros develops and manufactures bone graft biologics backed by Level I clinical trial evidence and 25+ orthobiologics patents. The tech stack reveals a compliance-heavy operational infrastructure—Veeva for content and document management, HighSpot for sales enablement, Azure Logic Apps and multiple RPA tools (UiPath, Automation Anywhere, Power Automate) for workflow automation—paired with manufacturing-focused hiring (6 active roles). This hiring velocity and mix suggests scaling production workflows and regulatory documentation processes to support multi-market commercialization, a critical constraint in orthobiologics.

Tech Stack 23 technologies

Core StackTableau Dynamics 365 Power BI HubSpot WordPress Canva Workato Informatica Power Automate Java .NET C# Python Microsoft Dynamics 365 Veeva HighSpot CRM Azure Logic Apps Boomi Snaplogic UiPath Automation Anywhere SOAP
AdoptingPower BI

What Kuros Biosciences Is Building

Challenges

  • Reducing cycle times
  • Content gaps
  • Clinical data translation
  • Operational risk mitigation
  • High-risk medical device compliance
  • Standardizing contracting practices
  • Complex regulatory documentation
  • Design documentation compliance
  • Eliminating inefficiencies
  • Process alignment

Active Projects

  • Shelf-life and validation studies
  • Quarterly dose audits
  • Content management on veeva
  • Sales enablement on highspot
  • Kuros campaign development
  • Design transfer to manufacturing
  • Process & template improvement
  • Building repeatable commercial workflows
  • Implementing process improvement initiatives
  • Deploying new tools and automating tasks

Hiring Activity

Accelerating25 roles · 25 in 30d

Department

Manufacturing
6
Clinical
5
Sales
4
Engineering
2
Marketing
2
Healthcare
1
HR
1
Legal
1

Seniority

Mid
13
Senior
7
Manager
3
Director
1
Junior
1

Notable leadership hires: Total Rewards Director

Company intelligence

Find more companies like Kuros Biosciences by tech stack, pain points and active projects

Get started free

About Kuros Biosciences

Kuros Biosciences is a publicly listed biotech company (SIX Swiss Stock Exchange, ticker KURN) with operations across Switzerland, the Netherlands, and the USA. The company manufactures and commercializes bone graft products, with clinical and sales operations spanning over 20 markets. The product portfolio is backed by decades of clinical trial data, including more than 20 Level I-IV clinical trials and over 400 patient evaluations. Manufacturing and clinical operations drive the largest share of current hiring, indicating active scaling of production capacity and regulatory compliance functions.

HeadquartersAlpharetta, Georgia
Company Size51–200 employees
Hiring MarketsUnited States

Frequently Asked Questions

What tech stack does Kuros Biosciences use?

Core stack includes Veeva for content/document management, Microsoft Dynamics 365 for CRM, HighSpot for sales enablement, Power BI for analytics, and multiple automation tools (UiPath, Automation Anywhere, Power Automate, Azure Logic Apps). Backend languages include Java, .NET, C#, and Python.

What is Kuros Biosciences working on?

Active projects include design transfer to manufacturing, shelf-life and validation studies, sales enablement deployment via HighSpot, content management in Veeva, process improvement automation, and repeatable commercial workflow development across multiple geographies.

Similar Companies in Medical Equipment Manufacturing

Other companies in the same industry, closest in size

How this profile is built

Kuros Biosciences's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.